Aldehyde dehydrogenase 1 can be used as a new marker of cancer stem cells in laryngeal cancer cells in vitro / 中华肿瘤杂志
Chinese Journal of Oncology
;
(12): 900-904, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-335366
ABSTRACT
<p><b>OBJECTIVE</b>To detect the expression of aldehyde dehydrogenase 1 in human laryngeal cancer cells in vitro, and to explore whether it can be used as a marker of stem cells in human laryngeal cancer.</p><p><b>METHODS</b>Fluorescence staining and flow cytometry were used to detect the expression of ALDH1 in a human laryngeal cancer Hep-2 cell line, and fluorescence activated cells sorting was used to separate ALDH1(br) cells. ALDH1 tumor cells were cultured and their ability of proliferation and differentiation was observed in vitro.</p><p><b>RESULTS</b>The expression of ALDH1 in Hep-2 cells was different. The number of cells highly expressing ALDH1 was 2.9% ± 0.6%. Compared with ALDH1(low) cells and unsorted cells, ALDH1(br) cells exhibited increased proliferation ability. In serum-containing RPM I1640 culture medium, the proportion of ALDH1(br) cells was decreasing as days passed. The percentage of ALDH1(br) cells decreased from 94.2% ± 3.8% to the level before sorting. The ALDH1(br) cells demonstrated enhanced tumorigenic ability in nude mice.</p><p><b>CONCLUSIONS</b>In the laryngeal cancer Hep-2 cell line, the highly ALDH1-expressing cells show a strong ability of differentiation, proliferation and tumorigenesis. It indicates that ALDH1 can be used as a new marker of stem cells of laryngeal cancer cells.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Patología
/
Células Madre Neoplásicas
/
Distribución Aleatoria
/
Biomarcadores de Tumor
/
Diferenciación Celular
/
Separación Celular
/
Neoplasias Laríngeas
/
Técnicas de Cultivo de Célula
/
Línea Celular Tumoral
/
Carga Tumoral
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Animales
/
Humanos
/
Masculino
Idioma:
Chino
Revista:
Chinese Journal of Oncology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS